Back to Search

JORGE PLUTZKY, MD

MD

Cardiovascular Disease Physician

NPI: 1639135023IndividualAccepts Medicare

Specialties, Licenses & Credentials

Cardiovascular Disease PhysicianPrimary

Internal Medicine — Cardiovascular Disease

Code: 207RC0000X

71170(MA)

CMS Specialties

PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)

Education

UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE

Class of 1986

Research & Publications (20)

Expansion and contraction: the mighty, mighty fatty acid.
PMID 19498375·Nat Med·2009
7-preclinical
Preventing type 2 diabetes and cardiovascular disease in metabolic syndrome: the role of PPARalpha.
PMID 17935055·Diab Vasc Dis Res·2007
8-other
A cardiologist's perspective on cardiometabolic risk.
PMID 18154744·Am J Cardiol·2007
6-review
Inflammation in atherosclerosis and diabetes mellitus.
PMID 15211097·Rev Endocr Metab Disord·2004
6-review
PPARs: altering clinical responses in Type 2 diabetes and atherosclerosis. Introduction.
PMID 15470904·Clin Cardiol·2004
8-other
The vascular biology of atherosclerosis.
PMID 14678867·Am J Med·2003
6-review
Medicine. PPARs as therapeutic targets: reverse cardiology?
PMID 14563997·Science·2003
7-preclinical
Diabetes as a vascular disease. Dyslipidemia as a target.
PMID 19667619·Postgrad Med·2003
8-other
The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis.
PMID 12957325·Am J Cardiol·2003
6-review
Inflammatory pathways in atherosclerosis and acute coronary syndromes.
PMID 11694213·Am J Cardiol·2001
6-review
Peroxisome proliferator-activated receptors in endothelial cell biology.
PMID 11561170·Curr Opin Lipidol·2001
6-review
Emerging concepts in metabolic abnormalities associated with coronary artery disease.
PMID 11198624·Curr Opin Cardiol·2000
6-review
Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
PMID 11122762·Curr Atheroscler Rep·2000
6-review
The pathologic continuum of diabetic vascular disease.
PMID 19179216·J Am Coll Cardiol·2009
6-review
PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice.
PMID 19065047·J Clin Invest·2009
7-preclinical
Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.
PMID 18411276·J Biol Chem·2008
8-other
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.
PMID 18502305·Lancet·2008
6-review
The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
PMID 18755353·J Am Coll Cardiol·2008
2-rct
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.
PMID 18958843·Diab Vasc Dis Res·2008
6-review
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
PMID 19068318·Am J Cardiol·2008
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
77 AVENUE LOUIS PASTEUR NRB 7, BRIGHAM AND WOMEN'S HOSPITAL CARDIOVASCULAR DIVISION
BOSTON, MA 02115

Location

Practice Location

77 AVENUE LOUIS PASTEUR NRB 7, BOSTON, MA
(617) 525-4360

Quick Facts

NPI
1639135023
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
40
Publications
20

Are you this provider?

Claim Your Profile